Correlation Between Calithera Biosciences and Virax Biolabs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Calithera Biosciences and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Calithera Biosciences and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Calithera Biosciences and Virax Biolabs Group, you can compare the effects of market volatilities on Calithera Biosciences and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Calithera Biosciences with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Calithera Biosciences and Virax Biolabs.

Diversification Opportunities for Calithera Biosciences and Virax Biolabs

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Calithera and Virax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Calithera Biosciences and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Calithera Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Calithera Biosciences are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Calithera Biosciences i.e., Calithera Biosciences and Virax Biolabs go up and down completely randomly.

Pair Corralation between Calithera Biosciences and Virax Biolabs

If you would invest (100.00) in Calithera Biosciences on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Calithera Biosciences or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Calithera Biosciences  vs.  Virax Biolabs Group

 Performance 
       Timeline  
Calithera Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Calithera Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Calithera Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Virax Biolabs Group 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Calithera Biosciences and Virax Biolabs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Calithera Biosciences and Virax Biolabs

The main advantage of trading using opposite Calithera Biosciences and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Calithera Biosciences position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.
The idea behind Calithera Biosciences and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets